No Data
Solasia Pharma Advances Oncology Pipeline, Expands Global Reach for Key Cancer Drugs
Solasia Pharma Posts Wider Quarterly Loss and Withholds 2026 Guidance
Solasia Pharma KK: Business Performance of Product Development and Related Activities (First Quarter of Fiscal Year Ending December 2026)
Solasia Pharma KK: Quarterly Financial Results for the First Quarter of the Fiscal Year Ending December 2026 (IFRS, Consolidated)
Nippon Paper, Nissan Chemical, Dentsu G, Duskin (15th) (1301-6045)
※The above calendar is tentative and subject to change based on corporate circumstances. --------------------------------------- May 15 (Fri) <1301> Kyokuyo <1379> Hokuto <1380> Akikawa Ranch <1384> Hokuryo <142A> Jinjib <1432> Doryoku <1435> RoboHome <1438> Gifu Garden <145A> El.
Growth 250, a segment of emerging stocks, edged lower on profit-taking, while drone-related stocks attracted buying interest (as of the 22nd).
The TSE Growth Market 250 Index edged slightly lower. Sixty percent of growth stocks declined, while 32% rose. According to a domestic securities firm, 'There were more declining stocks across the entire market,' and profit-taking emerged following gains in previous sessions. QD Laser and Trial HD rebounded lower, while Soleil continued its decline. Axel Space gained, and Free saw a significant rise. Power X extended its upward movement amid reports citing Defense Minister Shinjiro Koizumi, who stated, 'The domestic production of drones is essential.'